Table 3 Comparison between the survival and all-cause mortality groups after propensity score matching

N

3918

3694

 < 0.001

T. gondii seropositive, n (%)

1913 (48.8)

1893 (51.2)

0.037

Follow-up time (years)

24.1 [22.5, 25.5]

11 [6.2, 17.0]

 < 0.001

Race, n (%)

 < 0.001

 - Non-Hispanic white

1207 (30.8)

1989 (53.8)

 - Non-Hispanic black

1423 (36.3)

922 (25.0)

 - Mexican–American

1048 (26.7)

687 (18.6)

 - Other

240 (6.1)

96 (2.6)

Male, n (%))

1810 (46.2)

1974 (53.4)

 < 0.001

Age (years)

40.6 ± 14.5

67.2 ± 14.4

 < 0.001

Low family income, n (%)

896 (22.9)

777 (21.0)

0.057

Low educational level, n (%)

1365 (34.8)

2073 (56.1)

 < 0.001

Type 2 diabetes, n (%)

362 (9.2)

1091 (29.5)

 < 0.001

Hypertension, n (%)

1216 (31.0)

2548 (69.0)

 < 0.001

BMI (kg/m²)

27.1 ± 5.8

27.2 ± 5.6

0.819

Waist (cm)

91.7 ± 14.3

97.1 ± 13.6

 < 0.001

White blood cell (×10⁹/l)

6.9 ± 2.1

7.2 ± 2.7

 < 0.001

Hemoglobin (g/l)

133.7 ± 16.3

136 ± 14.1

 < 0.001

Platelets (× 10⁹/l)

278.3 ± 71

264.6 ± 76.4

 < 0.001

CRP (mg/dl)

0.4 ± 0.8

0.6 ± 1.0

 < 0.001

FBG (mmol/l)

5.3 ± 1.4

6.2 ± 2.7

 < 0.001

HbA1c (%)

5.4 ± 0.9

6.0 ± 1.3

 < 0.001

Cholesterol (mmol/l)

5.1 ± 1.1

5.6 ± 1.2

 < 0.001

Triglyceride (mmol/l)

1.5 ± 1.2

1.8 ± 1.5

 < 0.001

AST (U/l)

19 [16, 24]

20 [17, 24]

 < 0.001

ALT (U/l)

14 [10, 20]

12 [9, 17]

 < 0.001

Albumin (g/l)

41.4 ± 4.0

40.3 ± 3.7

 < 0.001

Creatinine (μmol/l)

88.4 [79.6, 106.1]

97.2 [88.4, 114.9]

 < 0.001

BUN (mmol/l)

4.7 ± 1.5

6.2 ± 2.7

 < 0.001

Uric acid (μmol/l)

306.3 ± 83.0

341.6 ± 94.4

 < 0.001